SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is trending as investors debate the potential for a take-private bid by Trian Partners, fueling speculation of a massive short squeeze among a heavily shorted float. While some community members are bullish on the turnaround strategy and institutional backing, others are highlighting recent sales struggles and intense competition in the fast-food sector.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is surging as investors react to a powerful Q2 earnings report featuring massive revenue growth and a bullish outlook on AI capacity pricing. The community is actively celebrating the stock's upward momentum, framing it as a direct defiance of prominent short sellers and fueling significant conversation around a potential short squeeze.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

Marathon Digital is trending as shareholders vent intense frustration over the companys recent stock performance and leadership under CEO Fred Thiel. Community discourse is dominated by concerns over the lack of signed AI data center tenants, continuous insider selling, and significant volatility, leading many to compare the company unfavorably to its sector peers.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is surging following a blockbuster quarterly report that shattered earnings expectations, highlighted by record-breaking backlog orders and exceptionally strong forward guidance that signals massive AI infrastructure demand. The community is actively debating the stock's significant growth potential versus valuation concerns, with many investors anticipating a major short squeeze and a significant price re-rating as the company expands its enterprise market footprint.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is rallying as investors react to strong quarterly earnings, a significant revenue backlog, and management's raised guidance despite heavy capital expenditures. The market is actively debating the company's long-term debt profile against surging AI infrastructure demand, with many traders discussing a potential short squeeze as institutional confidence holds firm.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending as investors focus on an upcoming Investor Day, where management is expected to provide critical updates on the NDA submission timeline for its wet AMD treatment, AXPAXLI. The community remains divided, with bullish participants betting on the potential of a best-in-class product and a possible buyout, while bears express skepticism over regulatory hurdles and the company's long-term commercial strategy.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is trending as investors brace for top-line Phase 2 data for its menopause drug, ABCL635, which the community views as a critical de-risking event for the company's antibody discovery platform. Despite ongoing debate regarding dilution and revenue performance, sentiment remains heavily focused on the clinical readout's potential to validate the company's long-term pipeline and shift market perception.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Cisco is surging following a strong quarterly report where the company significantly raised its AI infrastructure order outlook, signaling its pivotal role in the enterprise networking supercycle. Investors are reacting positively to the combination of impressive hyperscaler demand and a strategic workforce restructuring aimed at reallocating resources toward high-growth AI and security initiatives.

Quantinuum Inc. is a quantum computing platform that offers solutions like hardware platforms, developer tools, application libraries and solution-targeted intellectual property (“IP”). The company was founded on January 20, 2026 and is headquartered in Broomfield, CO.

Quantinuum Inc. - Ordinary Shares - Class A

Quantinuum Inc.

Quantinuum is generating significant investor attention following its recent IPO and a series of strategic collaborations with major technology firms, fueling debates about its long-term valuation compared to organic growth within the quantum sector. Community members are actively dissecting the stock's market debut, comparing its performance to other quantum-focused competitors, and monitoring its integration into broader industrial AI and cloud computing ecosystems.

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is trending after announcing successful Phase 3 trial results for its depression treatment, DT120, which met primary and secondary endpoints. The community is actively discussing the stock's clinical foundation, upcoming trial readouts for anxiety, and the potential impact of a concurrent secondary equity offering on share price.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MSTR is trending due to heightened community debate surrounding institutional accumulation of Bitcoin and the company's aggressive strategy of balancing share dilution with preferred stock buybacks. Traders are closely monitoring the stock's performance in relation to Bitcoin's price fluctuations as speculators weigh the potential for a rebound against ongoing concerns regarding corporate debt and treasury management.

Michael Saylor's MSTR Opens Its Bitcoin Credit Playbook To Investors Amid BTC Selling Spree

Equity

Strategy launched a public Bitcoin Credit model showing how its BTC holdings cover debt and preferred stock obligations.


How Nasdaq, S&P 500, Dow Futures Are Trading Ahead Of July Inflation Data Release

July’s consumer price index (CPI) report is in focus on Wednesday as investors hope for a reading as encouraging as June’s.

Wall Street Bulls Look Optimistic About Strategy (MSTR): Should You Buy?

The average brokerage recommendation (ABR) for Strategy (MSTR) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

XRP Price Drops To Its Lowest Level Since 2024 After Bitcoin’s Fourth Failed Attempt To Hold Above $64K 

Cryptocurrency

Bitcoin recovered above $64,000 after touching $63,770 during the session.


MSTR Sells Bitcoin Worth $108.6M: Peter Schiff Says Saylor Has Given Up On ‘Digital Credit’

Strategy now holds 840,447 Bitcoin for an aggregate purchase price of approximately $63.36 billion, the company said in a regulatory filing. 

MSTR, CRCL, BMNR Stocks Rally After Bitcoin Reclaims $65K Despite CLARITY Delay

Bitcoin climbed above $65,000 for the first time in August, lifting crypto-linked stocks.


Larry Lepard Says Bitcoin Is Still 'A Wild Animal' – But Institutional Buying Is Taming The Big Selloffs

A rising institutional footprint helped slow bitcoin sell-offs, and the current dip appears significantly less volatile than past crypto bear markets.

Arthur Hayes Says AI Spending Boom Is ‘Lehman, Not Apple’ – Sees Bitcoin Eventually Hitting $1M

AI is pulling liquidity, and concerns over Strategy are weighing on sentiment, Arthur Hayes said, which could push Bitcoin down before pushing it up.

Here's How Much $1000 Invested In Strategy 15 Years Ago Would Be Worth Today

Strategy (NASDAQ:MSTR) has outperformed the market over the past 15 years by 1.36% on an annualized basis producing an average annual return of 14.6%. Currently, Strategy has a market capitalization of $34.61 billion.read more...

Strategy Q2 Earnings Call Focuses on STRC Repair & Cash Buffer

MSTR is prioritizing STRC's return to par, stronger cash coverage and flexible Bitcoin sales after a weak second quarter.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Bearish Sentiment

Buying

Holding

Selling / Trimming

Watching from the sidelines

Stocktwits

Strategy

Stocktwits Polls

Bulls and bears are locked in a heated battle, with frequent callouts of prominent short-sellers and aggressive talk of potential squeezes.

Investors are actively debating the implications of the company's recent strategic sales of bitcoin holdings and share dilution tactics.

The stock continues to struggle against the psychological 100 level, serving as a primary pivot point for intraday traders and option flow analysis.

Traders are closely watching the upcoming CPI report, expecting it to dictate whether the stock holds key supports or breaks lower.

Feed

News

Sentiment

Earnings

Fundamentals

Info

MSTRStrategy

Fundamentals

Connect Stocktwits to ChatGPT

Latest MSTR News